EDITORIAL |
|
Cholesterol atheroembolic disease – emerging variant of acute kidney injury
|
4-10 |
|
Autosomal-dominant polycystic kidney disease: perspectives of treatment
|
11-15 |
|
Acute interstitial nephritis
|
16-21 |
|
Renal artery throbosis and thrombembolism: danger, thart must be controlled
|
22-25 |
|
Sodium homeostasis disorders: the multidisciplinary approach
|
26-30 |
HOTLINE TOPIC |
|
N.A. Moukhin, V.V. Fomin
Drug-induced kidney disease in HIV-infected patients: clinical variants, approaches to prevention
|
31-35 |
|
V.Yu. Shilo, A.Yu. Denisov
Treatment of anemia in chronic kidney disease: the present, the past and the future
|
36-42 |
STATE-OF-ART |
|
Yu.S. Miluvanova, L.Yu. Milovanova, L.V. Kozlovskaya
Variants of renal osteodystrophy
|
43-52 |
ORIGINAL PAPERS |
|
D.E. Kutepov, I.N. Pasechnik, A.V. Popov, N.V. Blohina
Hepato-renal syndrome: modern opportunities of therapy
|
53-56 |
|
M.V. Avdeeva, L.V. Scheglova
Opportunities of healthcare centers in detection of patients with kidney disease and cardiovascular risk
|
57-60 |
|
N.S. Kirshina, L.T. Pimenov
Chronic kidney disease risk factors in development of renal dysfunction in chronic heart failure patients
|
61-64 |
PAEDIATRIC NEPHROLOGY |
|
S.P. Fomina, I.V. Bagdasarova, T. Pavlenko
Steroid-resistant nephritic syndrome in childhood: single-centre experience
|
65-69 |
CASE REPORTS |
|
S.V. Guliaev, A.D. Meshkov, P.I. Novikov, A.G. Semenovikh, N.V. Nikiforova, N.R. Nosova
Efficacy of aggressive immunosuppressive therapy in patient with fulminant Shoenlein-Henoch purpura
|
70-74 |
SOCIAL ASPECTS OF NEPROLOGY |
|
N.I. Vilkova
Unresolved questions of diabetic nephropathy (part I)
|
75-78 |
EPONYM |
|
Wegener’s grenulomatosis
|
79-79 |
Русский
